https://orcid.org/0000-0002-3662-4355
References
- Buckley RH. 2004. Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution. Annu Rev Immunol. 22:625–55.
- Buckley RH. 2010. B-cell function in severe combined immunodeficiency after stem cell or gene therapy: a review. J Allergy Clin Immunol. 125(4):790–97.
- Buckley RH. 2011. Transplantation of hematopoietic stem cells in human severe combined immunodeficiency: longterm outcomes. Immunol Res. 49(1–3):25–43.
- Comans-Bitter WM, de Groot R, van den Beemd R, Neijens HJ, Hop WC, Groeneveld K, Hooijkaas H, van Dongen JJM. 1997. Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations. J Pediatr. 130(3):388–93.
- Dvorak CC, Hassan A, Slatter MA, Hönig M, Lankester AC, Buckley RH, Pulsipher MA, Davis JH, Güngör T, Gabriel M, et al. 2014. Comparison of outcomes of hematopoietic stem cell transplantation without chemotherapy conditioning by using matched sibling and unrelated donors for treatment of severe combined immunodeficiency. J Allergy Clin Immunol. 134(4):935–43.
- Heimall J, Puck J, Buckley R, Fleisher TA, Gennery AR, Neven B, Slatter M, Haddad E, Notarangelo LD, Baker KS, et al. 2017. Current knowledge and priorities for future research in late effects after hematopoietic stem cell transplantation (HCT) for severe combined immunodeficiency patients: a consensus statement from the second pediatric blood and marrow transplant consortium international conference on late effects after pediatric HCT. Biol Blood Marrow Transplant. 23(3):379–87.
- Kaplan S, Pinar G, Kaplan B, Aslantekin F, Karabulut E, Ayar B, Dilmen U. 2016. The prevalence of consanguineous marriages and affecting factors in Turkey: a national survey. J. Biosoc. Sci. 48(5):616–30.
- Kwan A, Abraham RS, Currier R, Brower A, Andruszewski K, Abbott JK, Baker M, Ballow M, Bartoshesky LE, Bonilla FA, et al. 2014. Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. JAMA. 312(7):729–38.
- Myers LA, Patel DD, Puck JM, Buckley RH. 2002. Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival. Blood. 99(3):872–78.
- Pai SY, Logan BR, Griffith LM, Buckley RH, Parrott RE, Dvorak CC, Kapoor N, Hanson IC, Filipovich AH, Jyonouchi S, et al. 2014. Transplantation outcomes for severe combined immunodeficiency, 2000-2009. N Engl J Med. 371(5):434–46.
- Picard C, Al-Herz W, Bousfiha A, Casanova JL, Chatila T, Conley ME, Cunningham-Rundles C, Etzioni A, Holland SM, Klein C, et al. 2015. Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. J Clin Immunol. 35(8):696–726.
- Qasim W, Gaspar HB, Thrasher AJ. 2004. Gene therapy for severe combined immune deficiency. Expert Rev Mol Med. 6(13):1–15.
- Railey MD, Lokhnygina Y, Buckley RH. 2009. Long term clinical outcome of patients with severe combined immunodeficiency who received related donor bone marrow transplants without pre-transplant chemotherapy or posttransplant GVHD prophylaxis. J Pediatr. 155(6):834–40.
- Rosen FS. 1997. Severe combined immunodeficiency: a pediatric emergency. J Pediatr. 130(3):345–46.
- Sanal O, Tezcan I. 2011. Thirty years of primary immunodeficiencies in Turkey. Ann N Y Acad Sci. 1238:15–23.
- Scarselli A, Di Cesare S, Capponi C, Cascioli S, Romiti ML, Di Matteo G, Simonetti A, Palma P, Finocchi A, Lucarelli B, et al. 2015. Longitudinal evaluation of immune reconstitution and B-cell function after hematopoietic cell transplantation for primary immunodeficiency. J Clin Immunol. 35(4):373–83.